The results indicate that dietary DHA supplementation at clinically realistic levels impaired cSiO2-triggered expression of IFN- and chemokine-related genes that are likely to play critical roles in autoimmune pathogenesis and glomerulonephritis. This evidence concerns the gene IFNA1 and glomerulonephritis.